EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

MARGIN: Randomized Trial of Arterial CT Portography Versus Standard Imaging Guidance for Percutaneous Thermal Ablation of Colorectal Liver Metastases

Gary Doppelt, Fabien de Oliviera, Chloe Minier, Thierry Chevallier, Jean-Paul Beregi, Boris Guiu, Julien Frandon

CardioVascular and Interventional Radiology · 2025

DOI: 10.1007/s00270-025-04267-5 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift CardioVascular and Interventional Radiology, 2025. Verfasst von Gary Doppelt und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Imaging, Nîmes University Hospital, University of Montpellier, Medical Imaging Group, 30029, Nîmes, France. gary.doppelt@gmail.…. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Liver Neoplasms, Catheter Ablation, Tomography, X-Ray Computed. Die Arbeit nennt 9 Literaturangaben. Gefördert von: Centre Hospitalier Universitaire de Nîmes.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: To assess whether arterial computed tomography portography guidance improves early local tumor control after percutaneous thermal ablation of small colorectal cancer liver metastases compared with standard-of-care imaging guidance, hypothesizing a ≥ 20% increase in complete ablation at 3 months confirmed by MRI and PET-CT. MATERIALS AND METHODS: This prospective, single-blind, two-center trial will randomize 88 adults (1:1) with up to three colorectal liver metastases ≤ 3 cm, including at least one not visible with ultrasound, to undergo ablation under either standard imaging guidance (intravenous contrast-enhanced CT, image fusion, or CT hepatic arteriography) or arterial portography after selective mesenteric or splenic catheterization in a hybrid angio-CT suite. Operators may use radiofrequency or microwave devices. The primary endpoint is complete ablation at 3 months on MRI and PET-CT. Secondary endpoints include lesion-level success, 12-month recurrence, safety, and a translational biobank. The sample size provides 80% power to detect a 20% absolute improvement (two-sided α = 0.05). RESULTS: Not applicable; protocol manuscript. EXPECTED GAIN OF KNOWLEDGE: The MARGIN trial will test whether arterial CT portography can improve complete ablation rates versus standard imaging in colorectal liver metastases. Beyond technical outcomes, it aims to refine image guidance strategies, optimize margin control, and generate high-level evidence for interventional oncology. The translational biobank will further link imaging findings to tumor biology and immune activation. CONCLUSION: This trial will test if arterial CT portography can improve early completeness of thermal ablation for colorectal liver metastases versus standard imaging. TRIAL REGISTRATION: ClinicalTrials.gov NCT05665322 (registered December 14, 2022). LEVEL OF EVIDENCE: Level 1b (randomized controlled trial).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsLiver NeoplasmsCatheter AblationTomography, X-Ray ComputedRadiography, InterventionalHumansSingle-Blind MethodProspective StudiesPositron Emission Tomography Computed TomographyRandomized Controlled Trials as TopicMaleFemaleContrast MediaMulticenter Studies as TopicMiddle Aged

Stichwörter der Autor:innen

Computed tomography portographyLiver metastasisPercutaneous thermal ablationRandomized trial

Substanzen

Contrast Media

Autor:innen und Institutionen

  • Department of Medical Imaging, Nîmes University Hospital, University of Montpellier, Medical Imaging Group, 30029, Nîmes, France. gary.doppelt@gmail.com.
  • Department of Medical Imaging, Nîmes University Hospital, University of Montpellier, Medical Imaging Group, 30029, Nîmes, France.
  • Department of Radiology, Saint-Eloi University Hospital, 80 Avenue Augustin Fliche, 34295, Montpellier, France.
  • Department of Biostatistics, Clinical Epidemiology, Public Health, and Innovation in Methodology (BESPIM), CHU de Nîmes, 30029, Nîmes, France.

Förderung

  • Centre Hospitalier Universitaire de Nîmes

Zitieren

APA

Doppelt, G., de Oliviera, F., Minier, C., Chevallier, T., Beregi, J. P., Guiu, B., & Frandon, J. (2025). MARGIN: Randomized Trial of Arterial CT Portography Versus Standard Imaging Guidance for Percutaneous Thermal Ablation of Colorectal Liver Metastases. CardioVascular and Interventional Radiology. https://doi.org/10.1007/s00270-025-04267-5

Vancouver

Doppelt G, de Oliviera F, Minier C, Chevallier T, Beregi JP, Guiu B, et al. MARGIN: Randomized Trial of Arterial CT Portography Versus Standard Imaging Guidance for Percutaneous Thermal Ablation of Colorectal Liver Metastases. CardioVascular and Interventional Radiology. 2025. doi:10.1007/s00270-025-04267-5

BibTeX
@article{Doppelt2025,
  author = {Doppelt, Gary and de Oliviera, Fabien and Minier, Chloe and Chevallier, Thierry and Beregi, Jean-Paul and Guiu, Boris and Frandon, Julien},
  title = {MARGIN: Randomized Trial of Arterial CT Portography Versus Standard Imaging Guidance for Percutaneous Thermal Ablation of Colorectal Liver Metastases},
  journal = {CardioVascular and Interventional Radiology},
  year = {2025},
  doi = {10.1007/s00270-025-04267-5}
}
Kostenlos starten →